Immunotherapy Produces 'Unprecedented Results' for Advanced ...

Tiffany Bostwick, PA, discussed how immunotherapy for advanced endometrial cancer has contributed to improved results compared with the previous standard of ...

In Landmark Study, Immunotherapy Boosts Survival of Advanced ...

A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients to a remarkable 92 percent.

In landmark study, immunotherapy boosts survi | EurekAlert!

A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients to a remarkable ...

Immunotherapy May Address 'Huge Need' in Advanced Endometrial ...

Amanda Duck, PA-C, RD, held a discussion during a Community Case Forum on the progress made in using immunotherapy to treat patients with ...

Expanded Role for Immunotherapy to Treat Endometrial Cancer - NCI

Results from two large clinical trials show that adding immunotherapy to standard treatment for advanced endometrial cancer, including ...

Recent Advances and Challenges in Cancer Immunotherapy - PMC

Immunotherapy harnesses a patient's immune system to target cancer and has resulted in novel therapeutic approaches and unprecedented clinical ...

Immunotherapy by Treatment Types - Cancer Research Institute

Immunotherapy has shown remarkable success in treating advanced cases of cancers like lung cancer, melanoma, advanced bladder, and kidney cancer, amongst ...

Spotlight on Immunotherapy: Pushing the Frontier of Cancer Medicine

As one example, long-term results from a clinical trial testing the ICI pembrolizumab for patients with advanced NSCLC showed that 23 percent lived 5 or more ...

Decoding the signs of response to cancer immunotherapy - Nature

Immune checkpoint inhibitors (ICIs) work by interfering with the mechanism that cancer cells use to evade the host's immune response. Drugs that block cytotoxic ...

Immunotherapy: Precision Medicine in Action

15-20% of patients achieve durable results with immunotherapy. 1,000. More ... unprecedented effect. The biggest need now is continued funding for ...

Rectal Cancer Disappears After Experimental Use of Immunotherapy

These same remarkable results would be repeated for all 42 people — and counting — in the MSK clinical trial. In every case, the rectal cancer ...

The New Immunotherapy Combinations in the Treatment of ...

Methods: In particular, the combination of anti-PD-1 nivolumab and anti-CTLA-4 ipilimumab has already provided groundbreaking positive results in the advanced ...

93 percent of advanced leukemia patients in remission after ...

93 percent of advanced leukemia patients in remission after immunotherapy ; Kristin Kleinhofer and Dr. David Maloney · Photo courtesy Kristin ...

Combo immunotherapy makes waves of cancer-fighting T cells

The study, which analyzed data from 36 patients treated with immunotherapy for advanced melanoma, found that the combination therapy produces ...

Immunotherapy drug shows long-lasting response in advanced ...

UCLA researchers have found that the immunotherapy drug pembrolizumab produces positive responses that are long-lasting and with fewer side ...

Clinically approved combination immunotherapy: Current status ...

ICI-based combination immunotherapies become a 1st-line therapy for major cancers. •. Atezolizumab plus bevacizumab has produced unprecedented efficacy in ...

Lung cancer immunotherapy: progress, pitfalls, and promises

Immune infiltration in a tumor is a significant hurdle in effective ACT therapy. NSCLC tumors produce substantial amounts of the chemokine ...

Immunotherapy in Older Adults With Advanced Cancers

Growing data support the clinical benefit of immunotherapy in the second line or beyond for patients with extensive-stage small cell lung cancer, particularly ...

A guide to cancer immunotherapy: from T cell basic science ... - Nature

In 1909, Paul Ehrlich hypothesized that the human body constantly generates neoplastic cells that are eradicated by the immune system. Lewis ...

Which treatment after first line therapy in NSCLC patients without ...

Cancer immunotherapy has produced an unprecedented durable response rate, thus shifting from traditional doublet chemotherapy to immunotherapy-based ...